Mate are you paying attention
1 You stated there should have been an RCT with SOC as the placebo
2 I pointed out that no parent would enrol in the trial as the placebo was a certain death sentence
3 Then the last post is obviously there is a certain SOC which they must be getting
Let’s start again …Grade 3-4 aGvHD has a mortality rate at present SOC of 85-90% at 180 days
With Rem-l the mortality rate at 1 year is about 30-35% at over 1 year
The question you have to ask is it ethical to have a placebo with no cross over for grade 3-4 disease which will mean certain death if you get the short straw
- Forums
- ASX - By Stock
- MSB
- MSB 2022 - The road to commercialisation
MSB 2022 - The road to commercialisation, page-603
-
- There are more pages in this discussion • 926 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 61151 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 0.950 |
6 | 59977 | 0.945 |
9 | 154571 | 0.940 |
4 | 44875 | 0.935 |
5 | 92633 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 61151 | 6 |
0.965 | 46785 | 5 |
0.970 | 48228 | 6 |
0.975 | 64461 | 2 |
0.980 | 31269 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |